Luis Alberto Flores

Luis Alberto Flores

Auto-generated profile, based on publicly available information

Luis Alberto Flores

Regional Health Management of Castilla y León, Valladolid, Spain

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2007 in Palliative Medicine
Verified
Journal Article
Closed access
PDF file
CCCarlos Centeno
Carlos Centeno
DCDavid Clark
David Clark
TLThomas Lynch
Thomas Lynch
JRJavier Racafort
Javier Racafort
DPDavid Praill
David Praill
AGAmelia Giordano
Amelia Giordano
The European Association for Palliative Care Task (EAPC) Force on the Development of Palliative Care in Europe was created in 2003 and the results of its work are now being reported in full, both here and in several other publications. The objective of the Task Force is to assess the degree of palliative care development in the European Region as defined by the World Health Organization (WHO). The Task Force is a collaboration between EAPC, the International Observatory on End of Life Care, Help the Hospices and the International Association for Hospice and Palliative Care. The University of Navarra have collaborated in the dissemination of results and is involved in further developments of this group. Four studies, each with different working methods, made up the study protocol: a literature review, a review of all the existing palliative care directories in Europe, a qualitative `Eurobarometer' survey and a quantitative `Facts Questionnaire' survey. The work of the Task Force covers the entire WHO European Region of 52 countries. In this article we present a comparative study on the development of palliative care in Europe, drawing on all four elements of the study. Different models of service delivery have been developed and implemented throughout the countries of Europe. For example, in addition to the UK, the countries of Germany, Austria, Poland and Italy have a well-developed and extensive network of hospices. The model for mobile teams or hospital support teams has been adopted in a number of countries, most notably in France. Day Centres are a development that is characteristic of the UK with hundreds of these services currently in operation. The number of beds per million inhabitants ranges between 45—75 beds in the most advanced European countries, to only a few beds in others. Estimates on the number of physicians working full time in palliative care are shown. The countries with the highest development of palliative care in their respective subregions as measured in terms of ratio of services per one million inhabitants are: Western Europe — UK (15); Central and Eastern Europe — Poland (9); Commonwealth of Independent States — Armenia (8). This paper also presents indicators on the development of palliative care based on the bibliometric analysis of scientific journals and on the vitality of the palliative care movement in each country. Palliative Medicine 2007; 21: 463—471

1 March 2009 in Journal of Pain and Symptom Management
Verified
Journal Article
Closed access
TLThomas Lynch
Thomas Lynch
DCDavid Clark
David Clark
CCCarlos Centeno
Carlos Centeno
JRJavier Rocafort
Javier Rocafort
LFLuis Alberto Flores
Luis Alberto Flores
MWMichael Wright
Michael Wright

1 September 2006 in Journal of Pain and Symptom Management
Verified
Journal Article
Closed access
ÁSÁlvaro Sanz
Álvaro Sanz
SHSilvia Hernansanz
Silvia Hernansanz
CGCelia Gutiérrez
Celia Gutiérrez
MVMaría Luisa del Valle
María Luisa del Valle
LFLuis Alberto Flores
Luis Alberto Flores

1 July 2000 in Palliative Medicine
Verified
Journal Article
Closed access
CCCarlos Centeno
Carlos Centeno
PAPedro Arnillas
Pedro Arnillas
SHSilvia Hernansanz
Silvia Hernansanz
LFLuis Alberto Flores
Luis Alberto Flores
MGMarcos Gómez
Marcos Gómez
FLFrancisco López-Lara
Francisco López-Lara
With the sponsorship of the Spanish Society of Palliative Care (SECPAL), two nation-wide studies from the University of Valladolid were carried out in 1996 and 1998 into the state of palliative care teams in Spain. This report is based on those studies and is the first overall analysis of the current situation of palliative care in Spain. A total of 143 programmes were identified and data were collected from 128 teams (89%): 53 were programmes with hospitalised patients, 75 for home-based patients and 15 were mixed programmes. From the activity data, provided by 75% of the teams, it may be estimated that each year 22 638 terminally ill patients receive palliative care attention. Of these, 18 021 (79.6%) are cancer sufferers. Of the patients who die from cancer each year in our country, 21.2% receive palliative care during the final weeks of life. More than 10 years have passed since the first teams in Spain started their work. The time has now come to recognize the reality of palliative care in our society and to adopt a national policy for terminally ill patients, in line with World Health Organization recommendations formulated in 1989.

1 January 2006 in Journal of Pain and Symptom Management
Verified
Journal Article
Closed access
SHSilvia Hernansanz
Silvia Hernansanz
CGCelia Gutiérrez
Celia Gutiérrez
ÁSÁlvaro Sanz
Álvaro Sanz
LFLuis Alberto Flores
Luis Alberto Flores
MVMaría Luisa del Valle
María Luisa del Valle

1 May 2020 in Current Oncology
Verified
Journal Article
Open access
ÁSÁlvaro Sanz
Álvaro Sanz
María Elena Sánchez-GutiérrezMaría Elena Sánchez-Gutiérrez
María Elena Sánchez-Gutiérrez
LPL.A. Flores Pérez
L.A. Flores Pérez
MRM.L. del Valle Rivero
M.L. del Valle Rivero
Background: In 2012, 11 standards describing best supportive care (BSC) in clinical trials in advanced cancer were defined through consensus statements. The consensus included 15 key components. Our objective was to analyze whether clinical trials that involved patients with advanced cancer and that included BSC in at least 1 arm met the standards and contained the key components. Methods: We reviewed clinical trials registered in ClinicalTrials.gov, the ISRCTN (International Standard Randomised Controlled Trial Number) registry, the EU Clinical Trials Register, and the International Clinical Trials Registry Platform for 2012–2018. We selected only phase iii studies in patients with advanced cancer that included BSC in at least 1 arm. We describe the characteristics of the trials, together with the definition and components of BSC. We analyzed how the trials met the standards and adopted the key components of BSC. Results: Of 193 trials retrieved, only 64 met the inclusion criteria; 36 of those trials (56%) had no definition of BSC. Less than 7% of the trials included even 3 of the 8 BSC standards that were defined to be included in the design of trials. Furthermore, trials mentioned only 5 of the 15 key components that the consensus defined to be fundamental, with symptom management appearing in 22% of trials and the other 4 components appearing in less than 8%. Summary: Most clinical trials registered during 2012–2018 that involved patients with cancer and an arm with BSC did not define the BSC concept. Hence, the design of those trials does not meet the consensus recommendations.